Brand Recall Hub

Riva Recalls in Canada

15 recalls found for Riva. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.

15 Riva Recalls

Health Products Type I
2025-07-03

RIVA-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetine

Product quality

View recall details →

Health Products Type III
2025-06-06

Rivasa 81 mg EC tablet; Out of specification (salicylic acid impurity)

Product quality

View recall details →

Health Products Type I
2025-04-29

RIVA-FLUOXETINE: Affected lots exceed the interim acceptable intake limit for N-nitroso-fluoxetine.

Product quality

View recall details →

Health Products Type III
2025-04-15

Riva Acetaminophen 500mg : Affected lot may contain 325mg Acetaminophen tablets

Product quality

View recall details →

Medical Devices Type II
2023-11-28

Nim Trivantage Emg Endotracheal Tube

Performance

View recall details →

Health Products Type II
2022-09-22

Riva-Oxazepam: Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406

Labelling

View recall details →

Medical Devices Type II
2022-01-04

Nim Trivantage Emg Endotracheal Tube

Performance

View recall details →

Other
2021-10-09

Recall: One lot of Riva-Risperidone 0.25 mg tablets recalled due to a packaging error

View recall details →

Health Products Type I
2021-10-07

Riva-Risperidone (2021-10-07)

Product safety

View recall details →

Other
2021-03-08

Two lots of Riva Senna 8.6 mg laxative tablets recalled due to microbial contamination

View recall details →

Health Products Type II
2021-03-03

Riva-Senna 8.6 mg(2021-03-03)

Product safety

View recall details →

Consumer Products
2021-02-04

Otis and CemcoLift Private Residence Elevators recalled due to Entrapment Hazard

View recall details →

Health Products Type I
2019-10-24

Laboratoire Riva Inc. Ranitidine Product Recall (2019-10-24)

Product safety

View recall details →

Other
2018-12-20

XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement

Product safety

View recall details →

Consumer Products
2018-02-01

Hunter Douglas Canada Limited Partnership recalls Hunter Douglas Luminette Privacy Sheers with Combo wand /cord in the White Diamond colour

Strangulation hazard

View recall details →